0.59 CME

Management of Hypertensive Emergency in ED

Speaker: Dr. Mohamad Wani

Associate Professor, Emergency Medicine, University of Birmingham, Consultant Emergency Medicine, Dudley Group NHS Foundation, England, United Kingdom

Login to Start

Description

Hypertensive emergency is defined as a severe elevation in blood pressure (typically ≥180/120 mmHg) accompanied by acute target-organ damage such as encephalopathy, stroke, myocardial ischemia, acute heart failure, aortic dissection, or acute kidney injury. Management requires immediate hospitalization and careful blood pressure reduction using intravenous agents like labetalol, nicardipine, or nitroprusside, depending on the clinical scenario. The goal is not rapid normalization, but controlled lowering of mean arterial pressure by about 20–25% within the first hour to prevent hypoperfusion. Subsequent reduction is gradual over the next 24–48 hours based on the underlying condition. Prompt identification of the precipitating cause and continuous hemodynamic monitoring are critical to improving outcomes.

Summary Listen

  • Hypertensive emergencies are defined by severely elevated blood pressure (typically >180/120 mmHg) accompanied by evidence of acute target organ damage. Common examples of such damage include hypertensive encephalopathy, acute stroke, acute heart failure/pulmonary edema, aortic dissection, acute kidney injury, and retinopathy. Differentiating hypertensive emergencies from hypertensive urgencies (similar blood pressure levels but without acute organ damage) is crucial, as emergencies require immediate intervention.
  • Common presentations of hypertensive emergencies in the emergency department include severe, atypical headaches, chest pain (cardiac or non-cardiac), acute breathlessness, neurological deficits/confusion, visual disturbances, and reduced urine output. Patients may arrive via ambulance or walk-in, necessitating prompt assessment and stabilization.
  • Initial management follows the ABCDE (airway, breathing, circulation, disability, exposure) approach. Investigations such as ECG, blood tests (troponin, full blood count, electrolytes, renal function), urine analysis, CT brain (if neurological symptoms are present), chest X-ray, and fundoscopy (if feasible) are crucial for assessing organ damage.
  • Management involves continuous cardiac and blood pressure monitoring in a monitored setting (ED, HDU, or ICU). The primary goal is controlled blood pressure reduction, avoiding rapid drops that can cause organ hypoperfusion. The general target is to reduce mean arterial pressure (MAP) by 20-25% within the first hour and gradually to 160/100 mmHg over the next 2-6 hours.
  • NICE and WHO guidelines emphasize rapid assessment for target organ damage, the use of IV antihypertensives, continuous blood pressure monitoring, and simultaneous investigation of the underlying cause (e.g., medication non-compliance, drug interactions, infection, cardiac event, aortic dissection). Common IV agents used in the UK include labetalol and GTN, titrated to effect.
  • WHO recommendations further support gradual blood pressure reduction using IV antihypertensives in a monitored environment. Treatment of associated complications (e.g., heart failure, stroke, acute kidney injury) is essential, often requiring consultation with specialist teams (e.g., cardiology, neurosurgery, renal). Continuity of care through effective communication with receiving specialty teams is paramount.
  • Clinical scenarios illustrate the application of these principles. Patients presenting with elevated blood pressure alongside headache and confusion (suggesting encephalopathy), dyspnea and crackles (suggesting pulmonary edema), or unilateral weakness (suggesting stroke) require targeted interventions and escalation to appropriate specialties.
  • Key learning points include recognizing hypertensive emergencies based on elevated blood pressure and organ damage, initiating controlled blood pressure reduction, assessing for underlying causes, adhering to NICE and WHO guidelines, managing organ-specific complications, and ensuring seamless team management for optimal patient outcomes.

Comments